AzPA Pharmacy Flash
Sep. 18, 2013

Fight against prescription abuse sees progress
The Republic
It started with an uptick in reported prescription drug abuse that analysts noticed in the state's annual youth survey. But as the analysts began examining prescription drug abuse in Arizona, they found data that showed the problem has spread far beyond the state's teenagers. More

Residency symposium and workshop: Developing, Expanding and Improving Residency Training Programs in Arizona

Friday, Oct. 18
Register today!

Need CE? AzPA Fall Pharmacy Conference: Expanding the Partnership of Pharmacy Care

Date: Saturday, Oct. 26.
This conference offers 6.0 contact hours (0.60 CEUs).More

PTCB Exam Prep Course

Completely revised!
Online and on demand.More

Registration now open for the AzPA Anticoagulation Certificate Program

Completely revised, the AzPA Anticoagulation Certificate Program will be presented Oct. 25. More

University of Arizona Medication Management Center receives URAC Drug Therapy Management Accreditation
The University of Arizona Medication Management Center, a unit of the UA College of Pharmacy, announced that it has been awarded Drug Therapy Management accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes quality standards for the healthcare industry. Accreditation is a rigorous and comprehensive evaluation process, and standards cover the essential parts of a DTM business. More

More pharmacies selling meth-resistant products
Parkersburg News and Sentinel
Following the announcement that one pharmacy chain recently to stock a tamper-resistant form of the drug used in the production of methamphetamine, other chains have said they too have a drug that is resistant to making meth. Fruth Pharmacy recently announced it is stocking a drug called Nexafed, which contains the active ingredient pseudoephedrine. But if an abuser tries to extract the pseudoephedrine out of Nexafed to make meth, it breaks down into a thick gel that thwarts production.More

Study: Cancer drug may be helpful for diabetes
HealthDay News
The cancer drug Zaltrap could help treat diabetes, suggest findings from research using mice. Scientists say they've identified a molecular pathway involved in the development of diabetes, and also found that the drug can regulate this pathway.More

Antipsychotic use in nursing home residents drops 9.1 percent
American Pharmacists Association
The national prevalence of antipsychotic use in long-stay nursing home residents went down 9.1 percent from the last quarter of 2011 to the first quarter of 2013, CMS has announced. The agency’s National Partnership to Improve Dementia Care has had a goal of reducing antipsychotic drug usage by 15 percent by the end of 2013, CMS said in a news release. Approximately 30,000 fewer nursing home residents are on these medications now than would have been.More

Hodgkin lymphoma treatment increases stomach cancer risk
Pharmacy Practice News
Treatment of Hodgkin lymphoma with certain radiation and chemotherapy regimens may put patients at increased risk for stomach cancer, according to a new study by scientists at the National Cancer Institute.More

Missed vaccinations increase whooping cough risk in young kids
Pharmacy Times
Although the United States is currently experiencing the largest outbreak of pertussis in 50 years, the number of U.S. children who do not receive all five recommended doses of the diphtheria, tetanus and acellular pertussis vaccine is increasing. The results of a recent study suggest that this trend in undervaccination is contributing to rising rates of pertussis, also known as whooping cough. More

Feasibility and effectiveness of a low-cost campaign on antibiotic prescribing in Italy: Community level, controlled, nonrandomized trial
Medical News Today
A local low-cost information campaign mainly targeted at citizens and involving doctors and pharmacists can significantly decrease total antibiotic prescribing, finds a paper published on The excessive use of antibiotics is associated with resistance to these drugs and an increasing threat to global health. Antibiotics are also often unnecessarily and inappropriately prescribed. This is an issue that has been frequently addressed by health information campaigns.More

Proposed opioid reduction guideline reduces depression, pain
A regimen of a slow and steady opioid tapering shows efficacy in helping patients with chronic pain taking high doses of the drugs to significantly reduce their dose, resulting in reduced pain and depression, a new study shows. More

Illegitimate companies threaten patients' receipt of FDA-approved drugs
American Society of Health-System Pharmacists
Purveyors of medications not approved by FDA have become so successful at selling their wares that the agency recently sought advice on how to better inform healthcare professionals about the risks posed by these products.More

CVS bans doctors 'over-prescribing' pain meds
Drug Topics
In response to the federal crackdown on prescription fraud, CVS Caremark has told physicians it believes over prescribe controlled substances to take their business elsewhere. More

HIPAA changes go into effect on Sept. 23 — Is your pharmacy ready?
Smart Retailing
An overview of some changes to HIPAA and resources to help you ensure your pharmacy's compliance.More

A new combo to prevent nausea and vomiting
Pharmacy Practice News
A Phase III study has demonstrated that NEPA, a fixed-dose combination of oral netupitant and palonosetron, is superior to oral palonosetron alone in preventing chemotherapy-induced nausea and vomiting.More

Ocular NSAID reduces macular edema after cataract surgery
The use of a topical ocular nonsteroidal anti-inflammatory drug before and after cataract surgery leads to meaningful reductions in postoperative macular edema in patients with pre-existing retinopathy, new research shows.More

Treatment options expand for psoriasis patients
HealthDay News
For the legions of Americans living with the red, scaly patches of psoriasis, doctors have good news. "We are at a point where we can help almost anyone, and we can do it fairly safely," said Dr. Mark Lebwohl, who chairs the National Psoriasis Foundation's medical board. "If you have psoriasis, there's usually a treatment out there that will make you better."More

Johnson & Johnson recalls some vials of antipsychotic treatment
The Wall Street Journal
Johnson & Johnson recently recalled another product, pulling some vials of its antipsychotic treatment Risperdal Consta after discovering mold during routine quality testing. In recent years, the New Brunswick, N.J., health products-maker has issued dozens of recalls for a variety of products, costing it hundreds of millions of dollars sales and prompting close government oversight of some manufacturing plants.More

Illegitimate companies threaten patients' receipt of FDA-approved drugs
American Society of Health-System Pharmacists
Purveyors of medications not approved by FDA have become so successful at selling their wares that the agency recently sought advice on how to better inform healthcare professionals about the risks posed by these products.More